Munich - Delayed Quote EUR

Spero Therapeutics Inc (2HA.MU)

Compare
0.5750
-0.0710
(-10.99%)
As of 8:02:13 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
27,396
27,396
96,735
48,579
3,070
Operating Expense
99,880
99,880
69,948
79,146
91,041
Operating Income
-72,484
-72,484
26,787
-30,567
-87,971
Net Non Operating Interest Income Expense
4,735
4,735
3,937
-1,499
-1,594
Other Income Expense
-817
-817
-5,320
-14,349
-191
Pretax Income
-68,566
-68,566
25,404
-46,415
-89,756
Tax Provision
--
--
2,598
--
--
Net Income Common Stockholders
-68,566
-68,566
22,806
-46,415
-89,756
Diluted NI Available to Com Stockholders
-68,566
-68,566
22,806
-46,415
-89,756
Basic EPS
0.08
-1.27
0.43
-1.23
-2.91
Diluted EPS
0.08
-1.27
0.43
-1.23
-2.91
Basic Average Shares
53,653.0530
54,037.9170
52,703.4670
37,585.0750
30,895.7560
Diluted Average Shares
53,938.6160
54,037.9170
52,989.0300
37,585.0750
30,895.7560
Total Operating Income as Reported
-73,361
-73,361
21,481
-42,197
-87,971
Total Expenses
99,880
99,880
69,948
79,146
91,041
Net Income from Continuing & Discontinued Operation
-68,566
-68,566
22,806
-46,415
-89,756
Normalized Income
-67,689
-67,689
27,569.3694
-35,702
-89,960
Interest Income
4,735
4,735
3,937
1,106
346
Interest Expense
4,545
--
--
2,605
1,940
Net Interest Income
4,735
4,735
3,937
-1,499
-1,594
EBIT
-72,484
-72,484
26,787
-43,810
-87,816
EBITDA
-72,482
-72,482
27,154
-42,941
-87,170
Reconciled Depreciation
2
2
367
869
646
Net Income from Continuing Operation Net Minority Interest
-68,566
-68,566
22,806
-46,415
-89,756
Total Unusual Items Excluding Goodwill
-877
-877
-5,306
-10,713
204
Total Unusual Items
-877
-877
-5,306
-10,713
204
Normalized EBITDA
-71,605
-71,605
32,460
-32,228
-87,374
Tax Rate for Calcs
--
--
0.0001
--
--
Tax Effect of Unusual Items
--
--
-542.6306
--
--
12/31/2021 - 10/13/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HQ1.MU Oruka Therapeutics Inc. R
8.25
-6.25%
 
5KW.F SkinBioTherapeutics plc
0.2780
-0.71%
 
ZH6.BE Biohaven Ltd. R
16.80
-10.16%
 
HPHA.F Heidelberg Pharma AG
2.8300
+0.35%
 
22Z.SG Zealand Pharma A/S
58.30
-6.65%
 
ASCLF Ascletis Pharma Inc.
1.2000
0.00%
 
22Z.F Zealand Pharma A/S
56.20
-6.02%
 
NP5.F Newron Pharmaceuticals S.p.A.
6.32
-10.99%
 
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
 
NKB2.F TG Therapeutics, Inc.
35.07
-1.21%